Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2021-05-05 Governance Information
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Quy chế nội bộ về quản trị công ty
Governance Information Classification · 94% confidence The document is titled "Quy chế nội bộ về quản trị công ty của Công ty Cổ phần Dược phẩm Imexpharm" and comprises the company’s internal regulations on corporate governance: scope, procedures for shareholder meetings, board nominations, duties of directors and controllers, and other governance frameworks. It does not present financial statements, AGM resolutions, or announcements, nor is it a presentation or call transcript. This matches the Governance Information category (CGR).
2021-05-05 Vietnamese
IMP: Quy chế hoạt động của HĐQT
Governance Information Classification · 90% confidence The document is the full text of the Governance Charter (‘Quy chế hoạt động của Hội đồng quản trị’) for Imexpharm’s Board of Directors, detailing internal rules, membership, roles, procedures, and governance practices. It is not an announcement or financial report but a comprehensive governance rule book. This matches the Governance Information category.
2021-05-05 Vietnamese
IMP: Nghị quyết HĐQT về việc ban hành điều lệ công ty và các quy chế hoạt động
Governance Information Classification · 82% confidence The document is a formal disclosure by Imexpharm to Vietnamese regulators announcing the approval and publication of amended corporate governance documents (Charter, internal governance regulations, Board and Supervisory Board rules) and includes the Board of Directors’ resolutions adopting these governance documents. This clearly falls under Governance Information (CGR).
2021-05-05 Vietnamese
IMP: Quy chế hoạt động của BKS
Governance Information Classification · 93% confidence The document is the internal regulation (‘Quy chế hoạt động’) for the company’s Supervisory Board, outlining scope, membership, duties, meeting procedures, reporting and governance relationships. It is neither a financial report nor an announcement but a governance charter detailing internal rules and board structure. This aligns with our Governance Information category (CGR).
2021-05-05 Vietnamese
IMP: Điều lệ công ty
Governance Information Classification · 95% confidence The document is the Articles of Association (“Điều lệ”) of Imexpharm, setting out the company’s internal rules, governance structure, board and shareholder meeting procedures, capital rules, etc. It does not present financial statements or meeting results, but rather details corporate governance practices. This matches the Governance Information category.
2021-05-05 Vietnamese
IMP: Nghị quyết và Biên bản họp ĐHĐCĐ thường niên năm 2021
AGM Information Classification · 85% confidence The document is the formal resolution (“Nghị Quyết”) and minutes (“Biên Bản”) of the 2021 Annual General Meeting of Imexpharm, including approved items, voting percentages, attendance details, and AGMspecific materials. It is not an earnings release, proxy statement, nor a standalone financial report, but rather the official AGM documents and decisions. This fits the “AGM Information” category (materials shared at the Annual General Meeting).
2021-04-26 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.